<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Onco Targets Ther</journal-id><journal-id journal-id-type="iso-abbrev">Onco Targets Ther</journal-id><journal-id journal-id-type="publisher-id">OTT</journal-id><journal-id journal-id-type="pmc">ott</journal-id><journal-title-group><journal-title>OncoTargets and therapy</journal-title></journal-title-group><issn pub-type="epub">1178-6930</issn><publisher><publisher-name>Dove</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32021253</article-id><article-id pub-id-type="pmc">6954091</article-id><article-id pub-id-type="publisher-id">227915</article-id><article-id pub-id-type="doi">10.2147/OTT.S227915</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Metformin Inhibits Proliferation of Human Thyroid Cancer TPC-1 Cells by Decreasing LRP2 to Suppress the JNK Pathway</article-title><alt-title alt-title-type="running-authors">He et al</alt-title><alt-title alt-title-type="running-title">He et al</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>He</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="AFF0001">1</xref><xref ref-type="author-notes" rid="FT0001"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Cao</surname><given-names>Lingling</given-names></name><xref ref-type="aff" rid="AFF0002">2</xref><xref ref-type="author-notes" rid="FT0001"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Li</given-names></name><xref ref-type="corresp" rid="AN0001"/><xref ref-type="aff" rid="AFF0001">1</xref><xref ref-type="aff" rid="AFF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Lingping</given-names></name><xref ref-type="aff" rid="AFF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="AFF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Gong</surname><given-names>Xuan</given-names></name><xref ref-type="aff" rid="AFF0001">1</xref></contrib><aff id="AFF0001"><label>1</label><institution>Department of Endocrinology, Zhuhai People&#x02019;s Hospital (Zhuhai Hospital Affiliated with Jinan University)</institution>, <addr-line>Zhuhai</addr-line>, <country>People&#x02019;s Republic of China</country></aff><aff id="AFF0002"><label>2</label><institution>Department of Endocrinology, Jiujiang No 1 People&#x02019;s Hospital (Affiliated Jiujiang Hospital of Nanchang University)</institution>, <addr-line>Jiujiang</addr-line>, <country>People&#x02019;s Republic of China</country></aff><aff id="AFF0003"><label>3</label><institution>School of Medicine, Hangzhou Normal University</institution>, <addr-line>Hangzhou</addr-line>, <country>People&#x02019;s Republic of China</country></aff></contrib-group><author-notes><corresp id="AN0001">Correspondence: Li Wang <institution>Department of Endocrinology, Zhuhai People&#x02019;s Hospital (Zhuhai Hospital Affiliated with Jinan University)</institution>, <addr-line>79 Kangning Road, Xiangzhou District</addr-line>, <addr-line>Zhuhai</addr-line>, <addr-line>Guangzhou</addr-line><addr-line>519000</addr-line>, <country>People&#x02019;s Republic of China</country><phone>Tel +86 13600365720</phone> Email zebushi629585858@163.com</corresp><fn id="FT0001"><label>*</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date pub-type="epub"><day>06</day><month>1</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>13</volume><fpage>45</fpage><lpage>50</lpage><history><date date-type="received"><day>20</day><month>8</month><year>2019</year></date><date date-type="accepted"><day>13</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2020 He et al.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>He et al.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution &#x02013; Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p></license></permissions><abstract><sec id="S2001"><title>Objective</title><p>To uncover the potential effect of metformin on proliferation and apoptosis of thyroid cancer TPC-1 cell line, and the underlying mechanism.</p></sec><sec id="S2002"><title>Methods</title><p>Viability, apoptosis and LRP2 level in TPC-1 cells treated with different doses of metformin for different time points were determined. Besides, protein levels of p-JNK1 and c-Jun N-terminal kinases (JNK) in metformin-treated TPC-1 cells were detected by Western blot. Regulatory effects of LRP2 on the JNK pathway and cell viability in metformin-treated TPC-1 cells were assessed.</p></sec><sec id="S2003"><title>Results</title><p>Viability in TPC-1 cells gradually decreased with the treatment of increased doses of metformin either for 24 h or 48 h. The apoptotic rate was concentration-dependently elevated by metformin treatment. Relative levels of LRP2 and p-JNK1 were concentration-dependently downregulated by metformin treatment. In addition, overexpression of LRP2 partially abolished the inhibitory effect of metformin on the viability of TPC-1 cells.</p></sec><sec id="S2004"><title>Conclusion</title><p>Metformin treatment suppresses the proliferative ability and induces apoptosis of TPC-1 cells by downregulating LRP2 to block the JNK pathway.</p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>metformin</kwd><kwd>LRP2</kwd><kwd>JNK</kwd><kwd>proliferation</kwd></kwd-group><counts><fig-count count="5"/><ref-count count="24"/><page-count count="6"/></counts></article-meta></front><body><sec sec-type="intro" id="S0001"><title>Introduction</title><p>Thyroid cancer is the most common malignancy in endocrine-related tumors. In recent years, thyroid cancer has been well concerned because of the rapid rise in its incidence.<xref rid="CIT0001" ref-type="bibr">1</xref> As a first-line drug applied for T2DM (type 2 diabetes mellitus), metformin contributes to stabilize blood glucose levels through inhibiting gluconeogenesis and reducing hepatic glycogenolysis.<xref rid="CIT0002" ref-type="bibr">2</xref> Interestingly, the application of metformin sharply decreases the incidences of tumor diseases, suppresses the growth of malignant cells and enhances chemotherapy-sensitivity.<xref rid="CIT0003" ref-type="bibr">3</xref> Therefore, metformin may exert a potential anti-tumor role. It is expected to be an adjuvant drug for the treatment of thyroid cancer.</p><p>LRP2 is a unique transmembrane receptor belonging to the family of low-density lipoprotein receptors (LDLR). It is highly similar to other members of the LDLR family in the structure.<xref rid="CIT0004" ref-type="bibr">4</xref> As a multi-ligand receptor, LRP2 interacts with lipoproteins, vitamin-binding proteins, hormones and enzymes based on its complement-like sequences, thus participating in transmembrane transport and re-absorption of multiple substances.<xref rid="CIT0005" ref-type="bibr">5</xref> Mutations in the LRP2 gene are closely related to plasma cholesterol and low-density lipoprotein levels.<xref rid="CIT0006" ref-type="bibr">6</xref> Therefore, LRP2 is able to regulate lipoprotein metabolism.</p><p>The c-Jun N-terminal kinases (JNK) signaling pathway is one of the critical members of the mitogen-activated protein kinase (MAPK) family.<xref rid="CIT0007" ref-type="bibr">7</xref> JNK is mainly expressed in the cytoplasm. Once it is activated, cytoplasmic JNK rapidly translocates into the nucleus and further activates transcription factors c-JUN and AP-1.<xref rid="CIT0008" ref-type="bibr">8</xref>,<xref rid="CIT0009" ref-type="bibr">9</xref> As a result, abundant apoptosis-related genes are activated.<xref rid="CIT0010" ref-type="bibr">10</xref> Meanwhile, the inflammatory response is activated as well.<xref rid="CIT0011" ref-type="bibr">11</xref>,<xref rid="CIT0012" ref-type="bibr">12</xref> In this paper, we mainly explored the regulatory effect of metformin on the proliferative and apoptotic changes in TPC-1 cells and the involvement of LRP2 and the JNK pathway.</p></sec><sec id="S0002"><title>Materials and Methods</title><sec id="S0002-S2001"><title>Cell Culture</title><p>Human thyroid cancer TPC-1 cells were cultured in Roswell Park Memorial Institute 1640 (RPMI 1640) (HyClone, South Logan, UT, USA) containing 10% fetal bovine serum (FBS) (Gibco, Rockville, MD, USA), 100 &#x003bc;g/mL penicillin and 0.1 mg/mL streptomycin, in a 37&#x000b0;C, 5% CO<sub>2</sub> incubator. Cultured cells displayed monolayer growth. Cell passage was conducted by 0.25% trypsin.</p></sec><sec id="S0002-S2002"><title>Cell Counting Kit-8 (CCK-8)</title><p>One hundred microliters of cell suspension (5&#x02013;8&#x000d7;10<sup>4</sup>/mL) was applied in the 96-well plate and cultured overnight. On the other day, cells were treated with different doses of metformin for different time points. Absorbance (A) at 450 nm was recorded at the appointed time points using the CCK-8 kit (Dojindo Laboratories, Kumamoto, Japan) for depicting the viability curves.</p></sec><sec id="S0002-S2003"><title>Apoptosis Determination</title><p>Cells were washed with phosphate-buffered saline (PBS) twice, centrifuged at 3000 r/min for 5 min and prepared for suspension (5&#x000d7;10<sup>4</sup>/mL). Cell suspension was diluted in 500 &#x003bc;L of binding buffer, incubated with 5 &#x003bc;L of Annexin V in dark for 15 min, and 5 &#x003bc;L of Propidium Iodide (PI) at 4&#x000b0;C, in the dark for another 15 min. After 5-min centrifugation at 3000 r/min, the precipitant was dissolved in 300 &#x003bc;L of binding buffer and subjected to flow cytometry.</p></sec><sec id="S0002-S2004"><title>Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)</title><p>Extraction of total RNA in cells was performed using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and RNA was subjected to reverse transcription. The extracted cDNA was applied for PCR using SYBR Green method (TaKaRa, Tokyo, Japan). Primer sequences were as follows: LRP2: F: 5&#x02032;-GATCTGTGACCTTCATTCCTGGCCTGATC-3&#x02032;, R: 5&#x02032;-GCCATGACACCTGTAGATGTGGTGCTGAATAATTGGTTAA-3&#x02032;; Glyceraldehyde 3-phosphate dehydrogenase (GAPDH): F: 5&#x02032;-ACTGCCACCCAGAAGACT-3&#x02032;, R: 5&#x002b9;-GCTCAGTGTAGCCCAGGAT-3&#x02032;.</p></sec><sec id="S0002-S2005"><title>Western Blot</title><p>Total protein was extracted from cells using radioimmunoprecipitation assay (RIPA) lysis butter and quantified by bicinchoninic acid (BCA) method (Beyotime, Shanghai, China). Protein sample was loaded for electrophoresis and transferred on polyvinylidene fluoride (PVDF) membranes (Millipore, Billerica, MA, USA). After blocking non-specific antigens in 5% skim milk for 2 hrs, membranes were subjected to incubation with primary and secondary antibodies. Bands were exposed by chemiluminescence (ECL) reagents and analyzed by Image Software (NIH, Bethesda, MD, USA).</p></sec><sec id="S0002-S2006"><title>Transfection</title><p>The cells were detached in 0.25% trypsin and prepared for suspension (5&#x000d7;10<sup>4</sup>/mL). Fifty pmol transfection vector and 2 &#x003bc;L of Lipofectamine<sup>TM</sup> 3000 (Invitrogen, Carlsbad, CA, USA) were, respectively, diluted in 100 &#x003bc;L of Opti-MEM<sup>&#x000ae;</sup> I. After 5-min maintenance at room temperature, they were mixed and let stand for another 20 min. Subsequently, the mixture was applied to the suspension. Transfected cells for 48 h were harvested for functional experiments.</p></sec><sec id="S0002-S2007"><title>Statistical Analysis</title><p>Statistical Product and Service Solutions (SPSS) 20.0 (IBM, Armonk, NY, USA) was used for data analyses. Data were expressed as mean &#x000b1; standard deviation. The differences among groups were statistically evaluated using Student&#x02019;s <italic>t</italic>-test when comparing only two groups or one-way analysis of variance (ANOVA) when comparing more than two groups. <italic>P</italic>&#x0003c;0.05 was considered as statistically significant.</p></sec></sec><sec id="S0003"><title>Results</title><sec id="S0003-S2001"><title>Metformin Suppressed Proliferation and Induced Apoptosis in TPC-1 Cells</title><p>TPC-1 cells were treated with 0, 1.25, 2.5, 5.0, 10.0 or 20.0 mM metformin for 24 or 48 h, respectively. As CCK-8 assay results revealed, the viability concentration-dependently decreased either after 24 or 48 h treatment (<xref rid="F0001" ref-type="fig">Figure 1A</xref>). In addition, the apoptotic rate in TPC-1 cells treated with 0, 10.0 or 20.0 mM metformin for 48 h gradually increased (<xref rid="F0001" ref-type="fig">Figure 1B</xref>). The above data supported the abilities of metformin to attenuate viability and induce apoptosis in TPC-1 cells.<fig id="F0001" fig-type="figure" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Metformin suppressed proliferation and induced apoptosis in TPC-1 cells. (<bold>A</bold>) Viability in TPC-1 cells treated with 0, 1.25, 2.5, 5.0, 10.0 or 20.0 mM metformin for 24 or 48 h, respectively. (<bold>B</bold>) Apoptotic rate in TPC-1 cells treated with 0, 10.0 or 20.0 mM metformin for 48 h (n=3, *<italic>p</italic>&#x0003c;0.05, significantly different from the 0 mM metformin group).</p></caption><graphic content-type="print-only" xlink:href="OTT-13-45-g0001"/></fig></p></sec><sec id="S0003-S2002"><title>Metformin Application Downregulated LRP2 in TPC-1 Cells</title><p>After treatment of 0, 10.0 or 20.0 mM metformin for 48 h, both protein and mRNA levels of LRP2 were downregulated, manifesting a dose&#x02013;response relationship (<xref rid="F0002" ref-type="fig">Figure 2A</xref> and <xref rid="F0002" ref-type="fig">B</xref>).<fig id="F0002" fig-type="figure" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Metformin application downregulated LRP2 in TPC-1 cells. (<bold>A, B</bold>) The mRNA (<bold>A</bold>) and protein (<bold>B</bold>) levels of LRP2 in TPC-1 cells treated with 0, 10.0 or 20.0 mM metformin for 48 h (n=3, *<italic>p</italic>&#x0003c;0.05, significantly different from the 0 mM metformin group).</p></caption><graphic content-type="print-only" xlink:href="OTT-13-45-g0002"/></fig></p></sec><sec id="S0003-S2003"><title>Metformin Application Inhibited the Activation of JNK Pathway in TPC-1 Cells</title><p>To clarify the involvement of the JNK pathway in metformin-mediated progression of thyroid cancer, protein levels of p-JNK1 and JNK1 were determined by Western blot. Protein level of p-JNK1 in TPC-1 cells was concentration-dependently downregulated by metformin treatment (<xref rid="F0003" ref-type="fig">Figure 3</xref>). However, the protein level of JNK1 remained unchangeable.<fig id="F0003" fig-type="figure" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Metformin application inhibited the activation of JNK pathway in TPC-1 cells. Protein levels of p-JNK1 and JNK1 in TPC-1 cells treated with 0, 10.0 or 20.0 mM metformin for 48 h (n=3, *<italic>p</italic>&#x0003c;0.05, significantly different from the 0 mM metformin group).</p></caption><graphic content-type="print-only" xlink:href="OTT-13-45-g0003"/></fig></p><p>It is speculated that LRP2 was involved in the inactivation of JNK pathway. Subsequently, pcDNA-LRP2 was constructed. Transfection of pcDNA-LRP2 effectively downregulated both mRNA and protein levels of LRP2 in TPC-1 cells, showing a pronounced transfection efficacy (<xref rid="F0004" ref-type="fig">Figure 4A</xref> and <xref rid="F0004" ref-type="fig">B</xref>).<fig id="F0004" fig-type="figure" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Transfection efficacy of pcDNA-LRP2. (<bold>A, B</bold>) The mRNA (<bold>A</bold>) and protein (<bold>B</bold>) levels of LRP2 in TPC-1 cells transfected with pcDNA-NC or pcDNA-LRP2 (n=3, *<italic>p</italic>&#x0003c;0.05, significantly different from the control group).</p></caption><graphic content-type="print-only" xlink:href="OTT-13-45-g0004"/></fig></p></sec><sec id="S0003-S2004"><title>Overexpression of LRP2 Abolished the Inhibitory Effects of Metformin on Cell Viability and Activation of the JNK Pathway</title><p>Transfection of pcDNA-LRP2 markedly reversed the inhibitory effect of metformin on protein levels of LRP2 and p-JNK1 in TPC-1 cells (<xref rid="F0005" ref-type="fig">Figure 5A</xref>). Moreover, decreased viability in metformin-treated TPC-1 cells was partially reversed by overexpression of LRP2 (<xref rid="F0005" ref-type="fig">Figure 5B</xref>). It is verified that LRP2 was responsible for metformin-induced viability suppression and JNK pathway inactivation.<fig id="F0005" fig-type="figure" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Overexpression of LRP2 abolished the inhibitory effects of metformin on cell viability and activation of the JNK pathway. TPC-1 cells were treated with NC, metformin or metformin+pcDNA-LRP2, respectively. (<bold>A</bold>) Protein levels of LRP2 and p-JNK1decreased significantly compared to the NC group, and overexpression of LRP2 reversed that. (<bold>B</bold>) Viability at 6, 24, 48, 72 and 96 h. Cell viability was decreased significantly compared to the NC group. Overexpression of LRP2 reversed this effect (n=3, *<italic>p</italic>&#x0003c;0.05; significantly different from the NC group or overexpression of LRP2 plus metformin group).</p></caption><graphic content-type="print-only" xlink:href="OTT-13-45-g0005"/></fig></p></sec></sec><sec id="S0004"><title>Discussion</title><p>A retrospective epidemiological study conducted by Evans et al<xref rid="CIT0013" ref-type="bibr">13</xref> in 2005 pointed out that the application of metformin markedly reduces the incidences of malignant tumors in patients with diabetes. Later, the tumor-suppressor effect of metformin has been well concerned. A relevant study demonstrated that metformin treatment suppresses tumor growth, elevates the complete remission rate and prolongs the disease-free survival in patients with thyroid cancer.<xref rid="CIT0014" ref-type="bibr">14</xref> Cho et al<xref rid="CIT0015" ref-type="bibr">15</xref> suggested that the application of different doses of metformin reduces the tumor volume and suppresses tumor cell growth in tumor-bearing nude mice. In a recent study, metformin like drug AICAR that affects cancer cell proliferation which in turn effective to create cell death in cancer cells via activating AMPK pathway.<xref rid="CIT0016" ref-type="bibr">16</xref> In this paper, metformin treatment markedly inhibited proliferative ability and induced apoptosis in TPC-1 cells. Furthermore, LRP2 level was downregulated and the JNK pathway was activated by metformin application.</p><p>The previous study has shown that LRP2 is mainly involved in regulations on lipoprotein transporter activity, low-density lipoprotein receptor activity, lipid metabolic process, lipoprotein transport, coronary vasculature development, aorta development, cell proliferation, ventricular septum development, clathrin-coated vesicle membrane, lysosome, etc. It is of significance in the etiology of acute myocardial infarction.<xref rid="CIT0017" ref-type="bibr">17</xref>,<xref rid="CIT0018" ref-type="bibr">18</xref> The JNK pathway is extensively involved in cellular behaviors, and its dysregulation is considered to be linked to disease progression.<xref rid="CIT0019" ref-type="bibr">19</xref>&#x02013;<xref rid="CIT0021" ref-type="bibr">21</xref> In MGC-803 cells (gastric cancer cells), JNK induces apoptosis through the mitochondrial pathway, triggering cytochrome release into the cytoplasm to initiate the apoptotic pathway.<xref rid="CIT0021" ref-type="bibr">21</xref>,<xref rid="CIT0022" ref-type="bibr">22</xref> Besides, metformin is able to activate the AMPK, mTOR/6SK, p-ERK and p70S6K/pS6 pathways.<xref rid="CIT0014" ref-type="bibr">14</xref>,<xref rid="CIT0023" ref-type="bibr">23</xref> It is capable of suppressing mitosis and proliferation of thyroid cancer stem cells and induces apoptosis.<xref rid="CIT0024" ref-type="bibr">24</xref> Our findings illustrated that metformin treatment inactivated the JNK pathway in TPC-1 cells, which could be abolished by overexpression of LRP2.</p><p>Collectively, metformin may be beneficial to inhibit the progression of thyroid cancer by downregulating LRP2 to inactivate the JNK pathway. Our findings provide new directions for the clinical treatment of thyroid cancer.</p></sec><sec id="S0005"><title>Conclusions</title><p>Metformin treatment suppresses the proliferative ability and induces apoptosis of TPC-1 cells by downregulating LRP2 to block the JNK pathway.</p></sec></body><back><sec id="S0006" sec-type="COI-statement"><title>Disclosure</title><p>The authors report no conflicts of interest in this work.</p></sec><ref-list><title>References</title><ref id="CIT0001"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Xu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zheng</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Qiu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Jia</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Yin</surname>
<given-names>S</given-names></string-name>. <article-title>Distinct metabolomic profiles of papillary thyroid carcinoma and benign thyroid adenoma</article-title>. <source><italic toggle="yes">J Proteome Res</italic></source>. <year>2015</year>;<volume>14</volume>(<issue>8</issue>):<fpage>3315</fpage>&#x02013;<lpage>3321</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acs.jproteome.5b00351</pub-id><pub-id pub-id-type="pmid">26130307</pub-id></mixed-citation></ref><ref id="CIT0002"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Zhen</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Dong</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Shen</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>QG</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>J</given-names></string-name>. <article-title>MiR-524 inhibits cell proliferation and induces cell apoptosis in thyroid cancer via targeting SPAG9</article-title>. <source><italic toggle="yes">Eur Rev Med Pharmacol Sci</italic></source>. <year>2018</year>;<volume>22</volume>(<issue>12</issue>):<fpage>3812</fpage>&#x02013;<lpage>3818</lpage>. doi:<pub-id pub-id-type="doi">10.26355/eurrev_201806_15265</pub-id><pub-id pub-id-type="pmid">29949157</pub-id></mixed-citation></ref><ref id="CIT0003"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Chung</surname>
<given-names>HH</given-names></string-name>, <string-name><surname>Moon</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Yoon</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>HW</given-names></string-name>, <string-name><surname>Won</surname>
<given-names>KC</given-names></string-name>. <article-title>The relationship between metformin and cancer in patients with type 2 diabetes</article-title>. <source><italic toggle="yes">Diabetes Metab J</italic></source>. <year>2013</year>;<volume>37</volume>(<issue>2</issue>):<fpage>125</fpage>&#x02013;<lpage>131</lpage>. doi:<pub-id pub-id-type="doi">10.4093/dmj.2013.37.2.125</pub-id><pub-id pub-id-type="pmid">23641353</pub-id></mixed-citation></ref><ref id="CIT0004"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Bu</surname>
<given-names>G</given-names></string-name>. <article-title>Apolipoprotein E and its receptors in alzheimer&#x02019;s disease: pathways, pathogenesis and therapy</article-title>. <source><italic toggle="yes">Nat Rev Neurosci</italic></source>. <year>2009</year>;<volume>10</volume>(<issue>5</issue>):<fpage>333</fpage>&#x02013;<lpage>344</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrn2620</pub-id><pub-id pub-id-type="pmid">19339974</pub-id></mixed-citation></ref><ref id="CIT0005"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Kozyraki</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Gofflot</surname>
<given-names>F</given-names></string-name>. <article-title>Multiligand endocytosis and congenital defects: roles of cubilin, megalin and amnionless</article-title>. <source><italic toggle="yes">Curr Pharm Des</italic></source>. <year>2007</year>;<volume>13</volume>(<issue>29</issue>):<fpage>3038</fpage>&#x02013;<lpage>3046</lpage>. doi:<pub-id pub-id-type="doi">10.2174/138161207782110507</pub-id><pub-id pub-id-type="pmid">17979745</pub-id></mixed-citation></ref><ref id="CIT0006"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Mii</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nakajima</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Fujita</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Genetic association of low-density lipoprotein receptor-related protein 2 (LRP2) with plasma lipid levels</article-title>. <source><italic toggle="yes">J Atheroscler Thromb</italic></source>. <year>2007</year>;<volume>14</volume>(<issue>6</issue>):<fpage>310</fpage>&#x02013;<lpage>316</lpage>. doi:<pub-id pub-id-type="doi">10.5551/jat.e494</pub-id><pub-id pub-id-type="pmid">18174661</pub-id></mixed-citation></ref><ref id="CIT0007"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>M</given-names></string-name>. <article-title>Antitumor effect of quercetin on Y79 retinoblastoma cells via activation of JNK and p38 MAPK pathways</article-title>. <source><italic toggle="yes">BMC Complement Altern Med</italic></source>. <year>2017</year>;<volume>17</volume>(<issue>1</issue>):<fpage>531</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12906-017-2023-6</pub-id><pub-id pub-id-type="pmid">29237430</pub-id></mixed-citation></ref><ref id="CIT0008"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Fung</surname>
<given-names>TS</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>DX</given-names></string-name>. <article-title>Activation of the c-Jun NH2-terminal kinase pathway by coronavirus infectious bronchitis virus promotes apoptosis independently of c-Jun</article-title>. <source><italic toggle="yes">Cell Death Dis</italic></source>. <year>2017</year>;<volume>8</volume>(<issue>12</issue>):<fpage>3215</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41419-017-0053-0</pub-id><pub-id pub-id-type="pmid">29238080</pub-id></mixed-citation></ref><ref id="CIT0009"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Jo</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>HS</given-names></string-name>, <string-name><surname>Seo</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Inhibitory effect of moschamine isolated from carthamus tinctorius on LPS-induced inflammatory mediators via AP-1 and STAT1/3 inactivation in RAW 264.7 macrophages</article-title>. <source><italic toggle="yes">Bioorg Med Chem Lett</italic></source>. <year>2017</year>;<volume>27</volume>(<issue>23</issue>):<fpage>5245</fpage>&#x02013;<lpage>5251</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bmcl.2017.10.035</pub-id><pub-id pub-id-type="pmid">29102229</pub-id></mixed-citation></ref><ref id="CIT0010"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Dhanasekaran</surname>
<given-names>DN</given-names></string-name>, <string-name><surname>Reddy</surname>
<given-names>EP</given-names></string-name>. <article-title>JNK-signaling: a multiplexing hub in programmed cell death</article-title>. <source><italic toggle="yes">Genes Cancer</italic></source>. <year>2017</year>;<volume>8</volume>(<issue>9&#x02013;10</issue>):<fpage>682</fpage>&#x02013;<lpage>694</lpage>. doi:<pub-id pub-id-type="doi">10.18632/genesandcancer.155</pub-id><pub-id pub-id-type="pmid">29234486</pub-id></mixed-citation></ref><ref id="CIT0011"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Lin</surname>
<given-names>CY</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>WH</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>SH</given-names></string-name>, et al. <article-title>Lipopolysaccharide-induced nitric oxide, prostaglandin E2, and cytokine production of mouse and human macrophages are suppressed by pheophytin-b</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source>. <year>2017</year>;<volume>18</volume>:<fpage>12</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms18122637</pub-id></mixed-citation></ref><ref id="CIT0012"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Han</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Bing</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Di</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Kinsenoside screening with a microfluidic chip attenuates gouty arthritis through inactivating NF-kappaB signaling in macrophages and protecting endothelial cells</article-title>. <source><italic toggle="yes">Cell Death Dis</italic></source>. <year>2016</year>;<volume>7</volume>(<issue>9</issue>):<fpage>e2350</fpage>. doi:<pub-id pub-id-type="doi">10.1038/cddis.2016.255</pub-id><pub-id pub-id-type="pmid">27584788</pub-id></mixed-citation></ref><ref id="CIT0013"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Evans</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Donnelly</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Emslie-Smith</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Alessi</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Morris</surname>
<given-names>AD</given-names></string-name>. <article-title>Metformin and reduced risk of cancer in diabetic patients</article-title>. <source><italic toggle="yes">BMJ</italic></source>. <year>2005</year>;<volume>330</volume>(<issue>7503</issue>):<fpage>1304</fpage>&#x02013;<lpage>1305</lpage>. doi:<pub-id pub-id-type="doi">10.1136/bmj.38415.708634.F7</pub-id><pub-id pub-id-type="pmid">15849206</pub-id></mixed-citation></ref><ref id="CIT0014"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Klubo-Gwiezdzinska</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Costello</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Patel</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer</article-title>. <source><italic toggle="yes">J Clin Endocrinol Metab</italic></source>. <year>2013</year>;<volume>98</volume>(<issue>8</issue>):<fpage>3269</fpage>&#x02013;<lpage>3279</lpage>. doi:<pub-id pub-id-type="doi">10.1210/jc.2012-3799</pub-id><pub-id pub-id-type="pmid">23709654</pub-id></mixed-citation></ref><ref id="CIT0015"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Cho</surname>
<given-names>SW</given-names></string-name>, <string-name><surname>Yi</surname>
<given-names>KH</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>SK</given-names></string-name>, et al. <article-title>Therapeutic potential of metformin in papillary thyroid cancer in vitro and in vivo</article-title>. <source><italic toggle="yes">Mol Cell Endocrinol</italic></source>. <year>2014</year>;<volume>393</volume>(<issue>1&#x02013;2</issue>):<fpage>24</fpage>&#x02013;<lpage>29</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mce.2014.05.021</pub-id><pub-id pub-id-type="pmid">24905037</pub-id></mixed-citation></ref><ref id="CIT0016"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Mukhopadhyay</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Chatterjee</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kogan</surname>
<given-names>D</given-names></string-name>, et al. <article-title>5-aminoimidazole-4-carboxamide-1-&#x003b2;-4-ribofuranoside (AICAR) enhances the efficacy of rapamycin in human cancer cells</article-title>. <source><italic toggle="yes">Cell Cycle</italic></source>. <year>2015</year>;<volume>14</volume>(<issue>20</issue>):<fpage>3331</fpage>&#x02013;<lpage>3339</lpage>. doi:<pub-id pub-id-type="doi">10.1080/15384101.2015.1087623</pub-id><pub-id pub-id-type="pmid">26323019</pub-id></mixed-citation></ref><ref id="CIT0017"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Cases</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Obry</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ben-Yacoub</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Impaired vitreous composition and retinal pigment epithelium function in the FoxG1:: LRP2myopic mice</article-title>. <source><italic toggle="yes">Biochim Biophys Acta Mol Basis Dis</italic></source>. <year>2017</year>;<volume>1863</volume>(<issue>6</issue>):<fpage>1242</fpage>&#x02013;<lpage>1254</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbadis.2017.03.022</pub-id><pub-id pub-id-type="pmid">28366874</pub-id></mixed-citation></ref><ref id="CIT0018"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>LL</given-names></string-name>, <string-name><surname>Ren</surname>
<given-names>RJ</given-names></string-name>, et al. <article-title>MicroRNA-146a represses LRP2 translation and leads to cell apoptosis in alzheimer&#x02019;s disease</article-title>. <source><italic toggle="yes">FEBS Lett</italic></source>. <year>2016</year>;<volume>590</volume>(<issue>14</issue>):<fpage>2190</fpage>&#x02013;<lpage>2200</lpage>. doi:<pub-id pub-id-type="doi">10.1002/1873-3468.12229</pub-id><pub-id pub-id-type="pmid">27241555</pub-id></mixed-citation></ref><ref id="CIT0019"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Chowdhury</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Mangiferin ameliorates acetaminophen-induced hepatotoxicity through APAP-Cys and JNK modulation</article-title>. <source><italic toggle="yes">Biomed Pharmacother</italic></source>. <year>2019</year>;<volume>117</volume>:<fpage>109097</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopha.2019.109097</pub-id><pub-id pub-id-type="pmid">31212128</pub-id></mixed-citation></ref><ref id="CIT0020"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Valvassori</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Gava</surname>
<given-names>FF</given-names></string-name>, <string-name><surname>Dal-Pont</surname>
<given-names>GC</given-names></string-name>, et al. <article-title>Effects of lithium and valproate on ERK/JNK signaling pathway in an animal model of mania induced by amphetamine</article-title>. <source><italic toggle="yes">Heliyon</italic></source>. <year>2019</year>;<volume>5</volume>(<issue>5</issue>):<fpage>e1541</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.heliyon.2019.e01541</pub-id></mixed-citation></ref><ref id="CIT0021"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Shen</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>ZG</given-names></string-name>. <article-title>JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species</article-title>. <source><italic toggle="yes">Free Radic Biol Med</italic></source>. <year>2006</year>;<volume>40</volume>(<issue>6</issue>):<fpage>928</fpage>&#x02013;<lpage>939</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2005.10.056</pub-id><pub-id pub-id-type="pmid">16540388</pub-id></mixed-citation></ref><ref id="CIT0022"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Takagi</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Nozaki</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Sugino</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Hattori</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Hashimoto</surname>
<given-names>N</given-names></string-name>. <article-title>Phosphorylation of c-Jun NH(2)-terminal kinase and p38 mitogen-activated protein kinase after transient forebrain ischemia in mice</article-title>. <source><italic toggle="yes">Neurosci Lett</italic></source>. <year>2000</year>;<volume>294</volume>(<issue>2</issue>):<fpage>117</fpage>&#x02013;<lpage>120</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0304-3940(00)01552-4</pub-id><pub-id pub-id-type="pmid">11058801</pub-id></mixed-citation></ref><ref id="CIT0023"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Klubo-Gwiezdzinska</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Jensen</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Costello</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells</article-title>. <source><italic toggle="yes">Endocr Relat Cancer</italic></source>. <year>2012</year>;<volume>19</volume>(<issue>3</issue>):<fpage>447</fpage>&#x02013;<lpage>456</lpage>. doi:<pub-id pub-id-type="doi">10.1530/ERC-12-0046</pub-id><pub-id pub-id-type="pmid">22389381</pub-id></mixed-citation></ref><ref id="CIT0024"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Chen</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Renko</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Derwahl</surname>
<given-names>M</given-names></string-name>. <article-title>Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents</article-title>. <source><italic toggle="yes">J Clin Endocrinol Metab</italic></source>. <year>2012</year>;<volume>97</volume>(<issue>4</issue>):<fpage>E510</fpage>&#x02013;<lpage>E520</lpage>. doi:<pub-id pub-id-type="doi">10.1210/jc.2011-1754</pub-id><pub-id pub-id-type="pmid">22278418</pub-id></mixed-citation></ref></ref-list></back></article>